Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Primary care

Community pharmacies to pilot CVD 'early detection service'

Community pharmacists will begin developing testing a service to rapidly detect cardiovascular conditions, NHS England has announced. 

From 1 October 2019, under the new community pharmacy contract, pharmacies will start to “develop and test” the new service referring patients on for further testing and treatment if required.

The service will start with blood pressure checks and may go on to include testing for atrial fibrillation, The Pharmaceutical Journal understands.

In a press release published on 2 September 2019, a spokesperson for NHS England said that pharmacists will “case-find and offer blood pressure tests to people showing symptoms, provide clinical and lifestyle advice or referral, and record the data, joining up services and treatment with GPs and other local services, to speed up access to care”.

If the service is successful, it could be expanded to all community pharmacies by 2021/2022, NHS England added.

Responding to the announcement, Keith Ridge, chief pharmaceutical officer for England, said: “This new contract makes the most of the clinical skills of local pharmacists and establishes pharmacies across England as local health hubs — open in the evenings and at weekends — where people can go for an ever-increasing range of clinical health checks and treatment.”

The Pharmaceutical Services Negotiating Committee (PSNC) welcomed the committment and indicated it could be implemented by April 2021 and could include testing for other conditions, such as atrial fibrillation.

Alastair Buxton, director of NHS services at the PSNC said: “The cardiovascular disease pilot in pharmacies is still in the planning stages, but it represents an important example of community pharmacy’s wider service ambitions and we are keen to see its commencement as soon as possible.”

The “high street heart checks” are part of targets laid out in the ‘NHS long-term plan’ to prevent tens of thousands of strokes and heart attacks over the next ten years.

This article was corrected on 5 September 2019 after NHS England clarified that electrocardiograms and cholesterol testing will not be provided in pharmacies under this new pilot, or in the NHS Health Check scheme.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207019

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Community Pharmacy Handbook

    Community Pharmacy Handbook

    Community Pharmacy Handbook is a survival guide for community pharmacists and students, answering your practical questions. Includes case studies.

    £33.00Buy now
  • Sampson's Textbook of Radiopharmacy

    Sampson's Textbook of Radiopharmacy

    This well-established textbook provides specialised information on the use of radiopharmaceuticals in the detection and treatment of diseases.

    £81.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.